A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult Participants
Status:
Recruiting
Trial end date:
2022-09-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics (PK) of a single oral dose of
JNJ-42847922 in adult participants with hepatic impairment when compared to healthy
participants with normal hepatic function.